ABCL

Abcellera Biologics stock hits 52-week high at 13.23 USD

ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know

AbCellera and Recursion Pharmaceuticals: two AI-drug stocks, two different stories

Abcellera Biologics stock hits 52-week high at 12.58 USD

AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

What'sGoing On With AbCellera Biologics Stock On Tuesday?

Abcellera Biologics stock hits 52-week high at 12.15 USD

Abcellera Biologics stock hits 52-week high at 11.51 USD

AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity

AbCellera prices $200 million public offering at $9.75/share

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

What's Going on With AbCellera Biologics Stock On Wednesday?

AbCellera Biologics (ABCL) Stock Sees Fair Value Lift After Clinical Data And Jazz Deal

Truist raises AbCellera stock price target on trial results